Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H22N2O3S2 |
Molecular Weight | 390.52 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)S(=O)(=O)N[C@H]1CCOC[C@@H]1C2=CC=C(C=C2)C3=CC=C(S3)C#N
InChI
InChIKey=FFAGHPLLBXWCSF-MSOLQXFVSA-N
InChI=1S/C19H22N2O3S2/c1-13(2)26(22,23)21-18-9-10-24-12-17(18)14-3-5-15(6-4-14)19-8-7-16(11-20)25-19/h3-8,13,17-18,21H,9-10,12H2,1-2H3/t17-,18+/m1/s1
Molecular Formula | C19H22N2O3S2 |
Molecular Weight | 390.52 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/23899905Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/20347881
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23899905
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/20347881
PF-4778574 is a potent AMPA receptor positive allosteric modulator (PAM) that has been shown to enhance cognition in animal models.Displacement studies using [3
H]PF-04725379 in rat cortical
tissue determined a Ki of 85 nM for PF-4778574. The AMPAR potentiator PF-4778574 was characterized in
a series of in vitro assays and acute-dose animal studies
evaluating AMPAR-mediated mechanism, safety, and nootropism.
Potentiator-induced animal effects were likely
purely AMPAR-dependent since PF-4778574 (10 uM) only
affected the dopamine transporter (IC50 of 910 nM) in a broad
human-based receptor/enzyme selectivity panel.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2096670 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23899905 |
45.0 nM [EC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23899905
Mice: A single dose (0.178 mg/kg) of PF-4778574 in 5:5:90 (v/v/v) DMSO:Cremophor EL:deionized H2O (0.0178 mg/ml) was administered (10 ml/kg s.c.) to CD-1 or C57BL/6J mice.
Rats: Intravenous Dose. From jugular vein–cannulated Sprague-Dawley rats receiving a single bolus (1 ml/kg i.v.) of PF-4778574 (0.2 mg/kg) in 2:98 (v/v) DMSO:20% hydroxypropyl-b-cyclodextrin (0.2 mg/ml).
Dogs: 0.1 mg/kg PO
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23899905
PF-4778574
concentration-dependently increased S-AMPA–evoked responses
in HEK293 cells expressing human GluA2i or
GluA2o, mouse neuronal precursors, and rat primary neurons.
Depending on the cell type, PF-4778574 EC50 ranged
from 45 to 919 nM. PF-4778574 (10 uM) only
affected the dopamine transporter (IC50 of 910 nM) in a broad
human-based receptor/enzyme selectivity panel
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:53:31 GMT 2023
by
admin
on
Sat Dec 16 09:53:31 GMT 2023
|
Record UNII |
TI55D82Z4B
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1219633-99-4
Created by
admin on Sat Dec 16 09:53:31 GMT 2023 , Edited by admin on Sat Dec 16 09:53:31 GMT 2023
|
PRIMARY | |||
|
44462786
Created by
admin on Sat Dec 16 09:53:31 GMT 2023 , Edited by admin on Sat Dec 16 09:53:31 GMT 2023
|
PRIMARY | |||
|
TI55D82Z4B
Created by
admin on Sat Dec 16 09:53:31 GMT 2023 , Edited by admin on Sat Dec 16 09:53:31 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->POSITIVE ALLOSTERIC MODULATOR (PAM) |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|